Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
0.9500
-0.0199 (-2.05%)
At close: Nov 20, 2026, 4:00 PM EST
1.040
+0.090 (9.47%)
After-hours: Nov 20, 2026, 4:36 PM EST
Cocrystal Pharma Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Cocrystal Pharma stock has a consensus rating of "Strong Buy" and an average price target of $8.00. The average 1-year stock price forecast is 742.11% higher than the current stock price, while the lowest is $6.00 (+531.58%) and the highest is $10 (+952.63%).
Price Target: $8.00 (+742.11%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Oct 9, 2026.
Analyst Ratings
The average analyst rating for Cocrystal Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $6 | Buy | Reiterates | $6 | +531.58% | Oct 9, 2026 |
| Noble Financial | Noble Financial | Buy Reiterates $10 | Buy | Reiterates | $10 | +952.63% | May 27, 2026 |
Financial Forecast
Revenue This Year
165.00M
Revenue Next Year
n/a
from 165.00M
Decreased by -100.00%
EPS This Year
-0.83
from -0.78
EPS Next Year
-0.55
from -0.83
EPS and Forward PE are based on non-GAAP adjusted numbers.